Related by context. All words. (Click for frequent words.) 67 pathogenic mechanisms 66 pathophysiologic 66 pathophysiological mechanisms 66 receptor subtypes 66 pathophysiological 65 Smad3 65 underlying pathophysiology 64 CaM kinase II 63 aetiological 63 gene polymorphisms 63 mitochondrial dysfunction 63 PPARγ 63 tyrosine phosphorylation 63 Notch signaling 63 hypothalamic pituitary adrenal axis 63 C1q 63 isoenzymes 63 renal fibrosis 63 cerebral microbleeds 63 pDCs 62 mechanistic studies 62 prostate carcinogenesis 62 TGF ß 62 plasminogen activators 62 DNA methylation patterns 62 P#X# receptor 62 genetic loci 62 Genetic variants 62 CRF antagonists 62 neuropathologic 62 Genetic predisposition 62 GRP# 62 ACh 62 HbF 62 neurocognitive impairment 62 Cognitive impairment 62 myocyte 62 genetic polymorphisms 62 de novo mutations 62 incidentalomas 62 selective inhibition 62 transgenic mouse model 62 ovarian hormones 62 miRs 62 CCR2 62 murine models 61 etiologic 61 etiologies 61 sonographic appearance 61 carcinoids 61 etiologic factors 61 pathophysiology 61 genetic polymorphism 61 KLF4 61 hamartomas 61 HPA axis 61 differential gene expression 61 TGF β 61 hyperalgesia 61 MAPK pathway 61 PTHrP 61 Aß 61 aetiology 61 signaling cascades 61 chromosomal rearrangement 61 bile acid metabolism 61 cAMP signaling 61 annexin 61 ADAM# 61 prognostic significance 61 mu opioid 61 TNF α 61 proteoglycan 61 TNFa 61 lung epithelium 61 Pseudomonas aeruginosa infections 61 mitochondrial toxicity 61 myocardial ischemia 61 infantile hemangioma 61 vasogenic edema 61 myogenic 61 neuroactive 61 BMP signaling 61 myeloproliferative diseases 61 biochemical abnormalities 61 WNK1 61 cellular pathways 61 oxysterols 61 NF kB pathway 61 MECP2 gene 61 TSLP 61 Mechanistic studies 61 neurogenic 61 synaptogenesis 61 neurite outgrowth 61 CB1 antagonists 61 IL 1ß 60 tumorigenicity 60 metabolic enzymes 60 chromosome #p#.# 60 neuroimaging studies 60 arterial calcification 60 renoprotective 60 extramedullary 60 protein tyrosine phosphatase 60 thromboembolic disease 60 molecular abnormalities 60 etiological 60 serine protease 60 MGUS 60 mesenchymal stromal cells 60 serotonin receptor 60 eNOS 60 ABCA1 60 CEACAM1 60 ADPKD 60 astrocytic 60 aberrant activation 60 PEDF 60 atherogenesis 60 underlying molecular mechanisms 60 metaplasia 60 cardiac troponin 60 gonadal hormones 60 endophenotypes 60 mtDNA mutations 60 amyloid deposition 60 synaptic function 60 nucleoli 60 lymphocyte activation 60 Leydig cell 60 autophagic 60 Fas ligand 60 calcineurin 60 TGF beta signaling 60 COX2 60 supratentorial 60 gene locus 60 glomerular 60 FGFs 60 mucinous 60 microvessels 60 paraneoplastic 60 neurocognitive deficits 60 nephrogenic 60 cypin 60 molecular biomarkers 60 adrenal cortex 60 hyperparathyroidism 60 thyrotropin 60 hypoperfusion 59 ERK signaling 59 hypometabolism 59 mosaicism 59 efferent 59 neurotrophic 59 histopathological examination 59 vascularisation 59 causal pathways 59 Prox1 59 paragangliomas 59 biologic pathways 59 mediated inhibition 59 Kupffer cells 59 GBA mutations 59 missense mutations 59 mesenteric 59 NFTs 59 monoclonal gammopathy 59 pathophysiologic mechanisms 59 cardiac conduction 59 NKT cells 59 gastric carcinoma 59 histone modifications 59 vascular dysfunction 59 melatonin receptor 59 pilocytic astrocytomas 59 ERK2 59 pharmacologic intervention 59 neuronal differentiation 59 LHRH agonists 59 sonographic diagnosis 59 COL#A# 59 acinar cells 59 microglial activation 59 tumor hypoxia 59 neuropsychological impairments 59 nongenetic 59 fascin 59 IGFBP2 59 haematopoietic 59 modulatory 59 airway remodeling 59 androgen receptor AR 59 histone acetylation 59 HMG CoA reductase 59 Foxp3 59 PDGF receptor 59 endogenous ligands 59 demyelinating 59 nicotinic receptor 59 beta adrenergic 59 adenosine receptors 59 agonist induced 59 Htt 59 COX enzymes 59 immunopathology 59 APOE genotype 59 antiapoptotic 59 primary aldosteronism 59 iNOS 59 eicosanoids 59 TNFalpha 59 ALK mutations 59 S#A# [002] 59 mitochondrial metabolism 59 serotonin synthesis 59 activin 59 neuronal plasticity 59 exocrine pancreas 59 virulence genes 59 gastrointestinal dysfunction 59 chromosomal aberrations 59 neuronal dysfunction 59 autonomic dysfunction 59 motor neuron degeneration 59 muscular dystrophies 59 anterior pituitary 59 alveolar epithelial cells 59 genomic alterations 59 HMGA2 59 ADAMTS# 59 prognostic marker 59 cystic lesions 59 USP# 59 myofibroblasts 59 p#/CBP 59 Abeta# 59 PTPN# 59 perivascular 59 splenic 59 NOD mice 59 mGlu2 3 59 oncogenesis 59 palytoxin 59 cyclophilin D 59 cardiogenic 59 primary cilia 59 neuronal stem cells 59 Six3 59 glycogen metabolism 59 cerebral ischemia 59 LRRK2 mutations 59 alexithymia 59 glutamatergic 59 inflammatory biomarkers 59 circadian genes 59 clinicopathologic 59 TAp# 59 MyoD 59 cyclooxygenase 2 59 PDE#A 59 adipokines 59 troponins 58 seminomas 58 P#X# 58 somatic mutations 58 NR2B 58 sortilin 58 hypogonadotropic hypogonadism 58 somatostatin 58 epigenetic mechanisms 58 NRG1 58 mGluR2 NAM 58 gene polymorphism 58 AV node 58 Lp PLA 2 58 Clusterin 58 AT1R 58 neuromuscular junction 58 Brodmann Area 58 adrenocorticotropic hormone 58 DNA demethylation 58 erythropoiesis 58 pleiotropic effects 58 transgenic mouse models 58 cell adhesion molecules 58 PPARgamma 58 physiologic mechanisms 58 beta1 integrin 58 activated microglia 58 ABCB1 58 podocyte 58 immunomodulatory effects 58 CIB1 58 epigenetically 58 immunoregulation 58 N Myc 58 sporadic ALS 58 connective tissue diseases 58 chemokine receptor 58 metabolic parameters 58 progranulin 58 SMN2 gene 58 PC# cells 58 radiographic findings 58 glucocorticoid receptor 58 GABAergic interneurons 58 glycosyltransferase 58 PKC inhibitors 58 monogenic 58 germline mutations 58 lymphoid cells 58 autoantigens 58 gliosis 58 LIS1 58 familial clustering 58 apelin 58 CNTNAP2 58 muscarinic receptors 58 Glucocorticoids 58 genetic syndromes 58 apoptotic pathway 58 clinicopathological 58 neovascularization 58 E#F# 58 pituitary hormone 58 synovial 58 estrogen receptor alpha 58 ependymomas 58 JAK STAT pathway 58 neuroendocrine 58 neurohormonal 58 hypocretin neurons 58 neoplastic 58 DISC1 58 GABAB receptors 58 mGluR 58 microvasculature 58 microdeletion 58 vitamin D receptors 58 constitutively 58 antiproliferative effects 58 cardiac myocytes 58 neuroregenerative 58 ATG#L# 58 constitutively active 58 inhibiting COX 58 familial pancreatic cancer 58 small molecule activators 58 lymphangiogenesis 58 epithelia 58 dietary interventions 58 TCF#L# gene 58 IPAH 58 endocannabinoid signaling 58 #q#.# [002] 58 demyelinating diseases 58 osteocalcin protein 58 substrate specificity 58 efalizumab 58 autoantigen 58 mitochondrial disorders 58 plasminogen 58 immunoregulatory 58 polycystin 58 artery stenosis 58 FSH receptor 58 estrogen receptor beta 58 glutamate signaling 58 micro RNAs 58 subclinical hypothyroidism 58 SMAD4 58 telomerase activation 58 diffusion tensor 58 myopathies 58 SLC#A# [002] 58 drug metabolizing enzymes 58 IGFBP 3 58 GABA receptor 58 epithelial barrier 58 surrogate markers 58 p# mutations 58 intraventricular 58 parvalbumin 58 NMDA receptor antagonists 58 prefrontal regions 58 leukoencephalopathy 58 Akt activation 58 Th2 responses 58 dentate gyrus 58 susceptibility gene 58 TNFR 58 osteoclast 58 mimetics 58 cells MSCs 58 fatty acid synthase 58 Schwann cell 58 caveolin 58 mitochondrial enzyme 58 cardiac biomarkers 58 chromosomal instability 58 amyloid formation 58 kinase inhibition 58 nAChR 58 nonischemic 58 Hox proteins 58 steroidogenesis 57 glutamate receptors 57 pressor response 57 untreated celiac disease 57 apoE 57 Hashimoto thyroiditis 57 intestinal epithelium 57 florbetaben 57 aberrant methylation 57 biochemical imbalance 57 HDACi 57 endogenous ligand 57 VEGF receptor 57 mutant huntingtin protein 57 chromosome condensation 57 costimulation 57 Aβ 57 gene rearrangements 57 physiological mechanisms 57 antiplatelet therapies 57 eotaxin 57 PPAR γ 57 cofactors 57 CALHM1 57 MAPCs 57 replicase 57 predisposing factor 57 splice variants 57 Hh 57 pathogenetic 57 glucocorticoid receptors 57 oxidized phospholipids 57 Nod1 57 p# MAPK 57 compensatory mechanisms 57 #ß 57 dysregulation 57 beta amyloid peptides 57 proto oncogene 57 conformational changes 57 kallikrein 57 Th2 cytokines 57 pancreatic endocrine 57 #β estradiol 57 IFN γ 57 lymphocytic 57 GABAergic 57 adult neurogenesis 57 antioxidant supplementation 57 TLE3 57 BH4 57 HIF 1α 57 podocytes 57 von Willebrand 57 CCL# 57 astrocyte 57 Kv#.# 57 enzyme inhibitors 57 membranous nephropathy 57 osteoblastic 57 monocytes macrophages 57 breast cancer metastasis 57 prognostic markers 57 PrPSc 57 genomic instability 57 CagA 57 tumoral 57 dystroglycan 57 cardioprotection 57 proteolytic cleavage 57 hamartoma 57 FTLD 57 renal cysts 57 cytoprotective 57 isoform 57 microvascular disease 57 mPFC 57 microRNA expression 57 torsade de pointes 57 HeFH 57 antithrombotic agents 57 osteoblast 57 CSF biomarkers 57 metabolic abnormality 57 chromatin structure 57 Karlseder 57 cytochrome c oxidase 57 TGFß 57 neuroinflammation 57 HepG2 cells 57 transmembrane receptor 57 synaptic transmission 57 CCR9 57 hyperinsulinemia 57 chronicity 57 recurrent miscarriage 57 autocrine 57 viral etiology 57 inflammatory cytokine 57 CYP #A# 57 β blockers 57 amyloidogenic 57 VAPRISOL 57 pharmacologic treatments 57 HBx 57 osteoid 57 airway hyperresponsiveness 57 idiopathic pulmonary 57 angiographically 57 melanocyte 57 HLA molecules 57 IDH1 mutation 57 uPA 57 subgroup analyzes 57 TGF ß1 57 choroidal neovascularization 57 sphingolipid 57 MIF protein 57 NOD2 57 mutational status 57 alpha synuclein protein 57 beta interferons 57 neurobiological mechanisms 57 cardioprotective effects 57 Tissue Factor 57 neuropsychiatric diseases 57 pRb 57 carotid plaque 57 somatic symptoms 57 cardiac dysfunction 57 metalloprotease 57 apoE4 57 innervation 57 osteochondromas 57 KIAA# 57 Vps# 57 clefting 57 intestinal permeability 57 vimentin 57 AMPA receptor 57 β amyloid 57 cardiolipin 57 TLR antagonists 57 NMDA receptor 57 epigenetic changes 57 cathepsins 57 autoregulation 57 inotropic 57 ERalpha 57 IDH mutations 57 thrombin receptor 57 beta globin gene 57 plasma kallikrein 57 myocardial fibrosis 57 vasoactive 57 neuropsychiatric disorders 57 Hedgehog signaling 57 PPARg 57 cardiotoxic effects 57 enkephalin 57 microvessel 57 secretory pathway 57 HDAC3 57 mRNA decay 57 transgene expression 57 Wnt signaling pathway 57 valvular heart disease 57 costimulatory 57 proapoptotic 57 Neuropeptide Y 57 neurological abnormalities 57 cell signaling pathways 57 BCL#A 57 alkalosis 57 MDSCs 57 G allele 57 genetic locus 57 hyperprolactinemia 57 medulloblastomas 57 anterior temporal 57 metabolic acidosis 57 mechanistic insights 57 brain lesions 57 prognostic variables 57 mitogenic 57 ventricular myocardium 57 epithelial tumors 57 myeloproliferative disorders 57 C5a receptor 57 immunomodulation 57 GPR# [002] 57 vascular endothelial 57 BDNF gene 57 platelet activation 57 atherosclerotic lesions 57 5 HT1A 57 adenomatous 57 endogenous opioid 57 hyperplastic 57 FGF signaling 57 p# activation 57 gastrin 57 dopaminergic 56 CHD7 56 ectodomain 56 noncardiac 56 galanin 56 denervation 56 periventricular 56 SSc 56 nicotinic receptors 56 Neurogenic 56 molecular mechanisms underlying 56 pro angiogenic 56 MT1 MMP 56 G6PD deficiency 56 VE cadherin 56 ERK1 2 56 cytochrome P# enzyme 56 chitinase 56 Wnt pathway 56 susceptibility loci 56 GABAA receptor 56 enteric nervous 56 TMEM#B 56 hypercoagulable 56 prostaglandin synthesis 56 Chronic pancreatitis 56 perfusion defects 56 alpha7 NNR 56 spondyloarthritis 56 varicella infection 56 diagnostic biomarker 56 leukocyte recruitment 56 clonal expansion 56 PON1 gene 56 Chlamydia pneumoniae 56 hyperactivation 56 neurologic symptoms 56 neuropsychiatric symptoms 56 diabetic polyneuropathy 56 PTEN gene 56 ciliopathies 56 enzymatic pathways 56 splice variant 56 Th# cells 56 Sgk1 56 VHL gene 56 transmembrane protein 56 promoter polymorphism 56 sGC 56 endothelial dysfunction 56 cannabinoid receptors 56 lymphoid 56 GPCR targets 56 COX inhibitors 56 EBNA1 56 plasma pharmacokinetics 56 thrombophilia 56 pharmacokinetic interactions 56 neurosteroids 56 calculi 56 antiplatelet drugs 56 CYP#C# [001] 56 protein kinase C 56 inhaled anesthetics 56 murine model 56 Symadex 56 hereditary predisposition 56 Nedd4 56 lung epithelial cells 56 steroidogenic 56 CYP #D# 56 bronchial epithelial cells 56 hypothalamic pituitary 56 nucleolar 56 FGF2 56 MYH9 56 synovial cells 56 mesothelial cells 56 androgen deficiency 56 repolarization 56 TNFα 56 cardiac hypertrophy 56 anticholinergic effects 56 cerebral vasospasm 56 mGluR5 inhibition 56 inactivating mutations 56 cDNAs 56 proinflammatory 56 vascular occlusion 56 CD4 + T lymphocytes 56 Cushing syndrome 56 primary hyperparathyroidism 56 ANCA associated 56 histologic examination 56 Notch1 56 gene inactivation 56 HuR 56 ataxias 56 FGFR2 gene 56 melanocortin receptors 56 proinflammatory cytokines 56 antiphospholipid antibodies 56 leiomyomas 56 IL 1β 56 dysbindin 56 colorectal adenocarcinoma 56 connexin 56 intracellular signal transduction 56 IFRD1 56 extracranial 56 physiologic responses 56 SIRT2 56 eIF2 56 IGF IR 56 Aâ 56 uPAR 56 Severe Primary IGFD 56 microvascular dysfunction 56 Treg cell 56 familial aggregation 56 epigenetic alterations 56 carcinoid 56 cytokine signaling 56 LRP5 56 silent myocardial ischemia 56 selective agonists 56 dysrhythmia 56 remyelination 56 epigenetic modifications 56 node metastasis 56 etiologic agent 56 neuronal pathways 56 NMDAR 56 causative genes 56 stratifying patients 56 anticholinergic agents 56 synapse formation 56 PKC isoforms 56 microRNAs miRNAs 56 etiological factors 56 VIPR2 56 SGLT2 inhibitors 56 coexpression 56 valvular heart 56 gastric adenocarcinoma 56 fibrocytes 56 biologic plausibility 56 EBV infection 56 selective modulator 56 urography 56 Cathepsin B 56 glycolipids 56 myelomas 56 white matter hyperintensities 56 E1A 56 neuroprotection 56 growth hormone secretion 56 myeloproliferative 56 antiangiogenic drugs 56 vasodilatory 56 neuroinflammatory 56 IKK beta 56 intracellular signaling 56 EGFR protein 56 GSK3B 56 clusterin 56 mdx mouse 56 POMC neurons 56 PARP inhibition 56 intestinal motility 56 HSF1 56 pathogenesis 56 AChE inhibitors 56 pathognomonic 56 underdiagnosis 56 antiepileptics 56 antiangiogenic 56 Estrogen Receptor 56 epigenetic modification 56 GPC5 56 XBP1 56 mammary cancers 56 nitric oxide synthase 56 chromosomal translocations 56 hepatocyte 56 homodimer 56 adrenocortical 56 carotid IMT 56 #HT#A 56 C. pneumoniae 56 nonalcoholic steatohepatitis NASH 56 noradrenergic 56 MDR1 56 anticonvulsants 56 nociception 56 EoE 56 synuclein 56 PI3K AKT 56 phosphatases 56 amyloid deposits 56 lesional 56 hypopituitarism 56 bone metabolism 56 #β HSD1 56 thyroglobulin 56 osteogenic differentiation 56 MAPK signaling pathway 56 microdeletions 56 neurobiological basis 56 myocardial dysfunction 56 baroreflex 56 neurosensory 56 cranial irradiation 56 vascular reactivity 56 inherited mutations 56 BPS IC 56 KCNE2 56 hypothalamic pituitary axis 56 GPIHBP1 56 dexrazoxane 56 microtubule targeting 56 CTGF 56 phospholipase 56 pDC 56 meningeal 56 periprocedural MI 56 mGluR5 antagonist 56 catecholamine 56 demyelination 56 P cadherin 56 amyloid cascade 56 upregulates 56 SH#B# 56 Thalomid ® 56 P gp 56 urothelial 56 etiology 56 SIBO 56 annexin V 56 excitatory synapses 56 diabetic kidney 56 p#INK#a 56 non coding RNA 56 hematopoiesis 56 K ras mutations 56 anti androgens 56 Amino acid 56 fibrotic disease 56 IKZF1 56 temporal arteritis 56 PDZ domain 56 chromosome aberrations 56 PPAR gamma agonists 56 PB1 F2 56 hypotensive 56 intraoperative complications 56 PAOD 56 lung fibrosis 56 BMP2 56 cerebellar 56 ERBB4 56 adrenal function 56 oligomeric 56 NKG2D 56 mutant SOD1 56 serotonergic neurons 56 6S RNA 56 microglial 56 MALAT1 56 genetic biomarkers 56 pain syndromes 56 mammalian proteins 56 ER alpha 56 Genetic variations 56 myo inositol 56 innate immune responses 56 oligomerization 56 IL#R 56 beta adrenergic receptors 56 parathyroid 56 γδ T cells 56 liver metastasis 56 comorbid disorders 56 aneuploidies 56 glitazones 56 membrane fusion 56 skeletal metastases 56 ABL1 55 Lyn kinase 55 downregulation 55 kinase gene 55 WT1 55 trophic factors 55 astrocytomas 55 Autoimmune disorders 55 metabolizing enzymes 55 cortical activation 55 EP1 receptor 55 brivaracetam 55 glycolipid 55 c myb 55 potent inhibitors 55 NR#A# 55 hyperacute 55 ERBB2 55 Wwox 55 hedgehog signaling 55 prognostic indicators 55 TGF alpha 55 Rab5 55 cortisol secretion 55 cannabinoid receptor 55 bone scintigraphy 55 tumor angiogenesis 55 mesothelin 55 alpha synuclein gene 55 mGluRs 55 renin angiotensin system 55 PDGFR 55 biologic pathway 55 pleiotropic 55 PGC 1α 55 multicenter trials 55 isotypes 55 vertebrate embryos 55 heme oxygenase 1 55 Prostatitis 55 neurologic deficits 55 polycythemia vera PV 55 cartilage degeneration 55 venous obstruction 55 TGF beta1 55 Protelos R 55 epigenetic regulation 55 Th2 immune 55 miR# 55 immune dysregulation 55 CENP E 55 potentially modifiable 55 Hypertrophic 55 guanine nucleotide exchange 55 oxidized lipids 55 alpha7 55 cytoskeletal structure 55 transcriptional activation 55 ApoE gene 55 developmental neurotoxicity 55 SCD1 55 melanocortin receptor 55 Stat3 55 prostate epithelial cells 55 molecular pathways 55 Fc receptor 55 B7 H4 55 cholinergic tone 55 transcriptional regulator 55 receptor subtype 55 miR #a [001] 55 CCN2 55 neurologic disorder 55 Neurogenesis 55 vertebral subluxation 55 histopathologic examination 55 molecular signaling pathway 55 hyperoxia 55 N myc 55 cardiomegaly 55 FXIII 55 thalamic 55 PGRN 55 acetylcholine receptor 55 Wnt signaling 55 inhibitory neurotransmitters 55 muscarinic 55 cediranib 55 nNOS 55 thrombolytic agents 55 Wnts 55 serotonergic 55 neuronal signaling 55 neoplastic cells 55 immune modulating 55 IgA deficiency 55 transcriptional regulation 55 telomere dysfunction 55 orthologs 55 Purkinje cell 55 eculizumab therapy 55 mRNA expression 55 subcortical